Amgen Inc

Stock Chart, Company Information, and Scan Results

$329.89(as of Dec 5, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Amgen Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$329.89
Ticker SymbolAMGN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees28,000
CountyUSA
Market Cap$177,639.4M
EBIDTA16,481.0M
10-Day Moving Average339.43
P/E Ratio25.52
20-Day Moving Average336.30
Forward P/E Ratio15.70
50-Day Moving Average310.27
Earnings per Share12.93
200-Day Moving Average292.51
Profit Margin33.65%
RSI51.74
Shares Outstanding538.5M
ATR7.84
52-Week High346.38
Volume2,897,992
52-Week Low245.31
Most Recent Support Level336.25
Book Value9,619.0M
Most Recent Resistance Level346.38
P/B Ratio18.59
Upper Keltner353.93
P/S Ratio4.97
Lower Keltner318.67
Debt-to-Equity Ratio353.93
Next Earnings Date02/02/2026
Cash Surplus-12,346.0M
Next Ex-Dividend DateUnknown

Amgen is a leader in medicinal breakthroughs as it pioneered ways to use living cells to develop biological medicines. The biotech develops and commercializes drugs to treat conditions like cancer, cardiovascular disease, and bone health. The company’s top-selling drugs, Aranesp and Kyprolis, are used to treat anemia and cancer respectively.

Amgen Inc In Our Stock Scanner

As of Dec 08, 2025
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.